These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35372112)

  • 61. Determination of imbalance between MMP-2 and TIMP-2 in human neuroblastoma by reverse-transcription polymerase chain reaction and its correlation with tumor progression.
    Ara T; Kusafuka T; Inoue M; Kuroda S; Fukuzawa M; Okada A
    J Pediatr Surg; 2000 Mar; 35(3):432-7. PubMed ID: 10726683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis.
    Huang Y; Shen L; Cai A; Xiao J
    J Tradit Chin Med; 2015 Oct; 35(5):571-6. PubMed ID: 26591688
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy.
    Bautista-López NL; Morillo CA; López-Jaramillo P; Quiroz R; Luengas C; Silva SY; Galipeau J; Lalu MM; Schulz R
    Am Heart J; 2013 Apr; 165(4):558-66. PubMed ID: 23537973
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
    Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA
    Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of metalloproteinases-2, -9, and -13 post photobiomodulation in mice talocrural joint.
    Abduch TF; da Silva PAV; de Souza ÁC; Dos Anjos LMJ; de Souza da Fonseca A; de Paoli F
    Lasers Med Sci; 2020 Apr; 35(3):633-640. PubMed ID: 31420795
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy.
    Ohtsuka T; Nishimura K; Kurata A; Ogimoto A; Okayama H; Higaki J
    J Card Fail; 2007 Nov; 13(9):752-8. PubMed ID: 17996824
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
    Young KA; Hennebold JD; Stouffer RL
    Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and extracellular metalloproteinase inducer by interleukin-17 in human periodontal ligament fibroblasts.
    Wu Y; Zhu L; Wei H; Peng B
    J Endod; 2013 Jan; 39(1):62-7. PubMed ID: 23228259
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.
    Lichtinghagen R; Huegel O; Seifert T; Haberkorn CI; Michels D; Flemming P; Bahr M; Boeker KH
    Clin Chem; 2000 Feb; 46(2):183-92. PubMed ID: 10657374
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
    Chavey C; Mari B; Monthouel MN; Bonnafous S; Anglard P; Van Obberghen E; Tartare-Deckert S
    J Biol Chem; 2003 Apr; 278(14):11888-96. PubMed ID: 12529376
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
    Voloshenyuk TG; Gardner JD
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression and localization of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct during pause in laying induced by tamoxifen.
    Leśniak-Walentyn A; Hrabia A
    Theriogenology; 2017 Jan; 88():50-60. PubMed ID: 27865412
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices.
    Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM
    Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the regression of chicken postovulatory follicles.
    Hrabia A; Socha JK; Sechman A
    Gen Comp Endocrinol; 2018 May; 260():32-40. PubMed ID: 29438675
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunohistochemical determination of the extracellular matrix modulation in a rat model of choline-deprived myocardium: the effects of carnitine.
    Strilakou A; Perelas A; Lazaris A; Papavdi A; Karkalousos P; Giannopoulou I; Kriebardis A; Panayiotides I; Liapi C
    Fundam Clin Pharmacol; 2016 Feb; 30(1):47-57. PubMed ID: 26501493
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.